Genetic Mutations Affecting Mitochondrial Function in Cancer Drug Resistance

Overview

Journal Genes Genomics

Specialty Genetics

Date 2023 Jan 7

PMID 36609747

Authors

Chanhaeng Lee

Sang-Hee Park

Sungjoo Kim Yoon

Affiliations

Soon will be listed here.

Abstract

Mitochondria are organelles that serve as a central hub for physiological processes in eukaryotes, including production of ATP, regulation of calcium dependent signaling, generation of ROS, and regulation of apoptosis. Cancer cells undergo metabolic reprogramming in an effort to support their increasing requirements for cell survival, growth, and proliferation, and mitochondria have primary roles in these processes. Because of their central function in survival of cancer cells and drug resistance, mitochondria are an important target in cancer therapy and many drugs targeting mitochondria that target the TCA cycle, apoptosis, metabolic pathway, and generation of ROS have been developed. Continued use of mitochondrial-targeting drugs can lead to resistance due to development of new somatic mutations. Use of drugs is limited due to these mutations, which have been detected in mitochondrial proteins. In this review, we will focus on genetic mutations in mitochondrial target proteins and their function in induction of drug-resistance.

Citing Articles

Sterol regulatory element binding transcription factor 1 is an important prognostic factor for colon adenocarcinoma and closely related to immune infiltration.

Jin L, Lin Z, Jin A Cytojournal. 2025; 21:67.

PMID: 39917010 PMC: 11801665. DOI: 10.25259/Cytojournal_43_2024.

Aging through the lens of mitochondrial DNA mutations and inheritance paradoxes.

Chen J, Li H, Liang R, Huang Y, Tang Q Biogerontology. 2024; 26(1):33.

PMID: 39729246 DOI: 10.1007/s10522-024-10175-x.

The MAPK/ERK signaling pathway involved in Raddeanin A induces apoptosis via the mitochondrial pathway and G2 phase arrest in multiple myeloma.

Jiang M, Li C, Mao C, Yu H, Zhou Y, Pu S Sci Rep. 2024; 14(1):29061.

PMID: 39580496 PMC: 11585587. DOI: 10.1038/s41598-024-76465-z.

Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer.

Cui X, Xu J, Jia X J Transl Med. 2024; 22(1):968.

PMID: 39456101 PMC: 11515418. DOI: 10.1186/s12967-024-05770-y.

MTCH2 promotes the malignant progression of ovarian cancer through the upregulation of AIMP2 expression levels, mitochondrial dysfunction and by mediating energy metabolism.

Sun G, Song Y, Li C, Sun B, Li C, Sun J Oncol Lett. 2024; 28(4):492.

PMID: 39185493 PMC: 11342418. DOI: 10.3892/ol.2024.14625.

References

Zong W, Rabinowitz J, White E . Mitochondria and Cancer. Mol Cell. 2016; 61(5):667-676. PMC: 4779192. DOI: 10.1016/j.molcel.2016.02.011. View

Dang L, White D, Gross S, Bennett B, Bittinger M, Driggers E . Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009; 462(7274):739-44. PMC: 2818760. DOI: 10.1038/nature08617. View

Redza-Dutordoir M, Averill-Bates D . Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016; 1863(12):2977-2992. DOI: 10.1016/j.bbamcr.2016.09.012. View

Qiao S, Lu W, Glorieux C, Li J, Zeng P, Meng N . Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer. Oncogene. 2021; 40(39):5880-5892. DOI: 10.1038/s41388-021-01968-2. View

Xu M, Chen S, Yang W, Cheng X, Ye Y, Mao J . FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer. Cell Physiol Biochem. 2018; 47(1):151-160. DOI: 10.1159/000489759. View

Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno A, Le Toumelin-Braizat G . The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models. Nature. 2016; 538(7626):477-482. DOI: 10.1038/nature19830. View

Nekrutenko A, Hillis D, Patton J, Bradley R, Baker R . Cytosolic isocitrate dehydrogenase in humans, mice, and voles and phylogenetic analysis of the enzyme family. Mol Biol Evol. 1998; 15(12):1674-84. DOI: 10.1093/oxfordjournals.molbev.a025894. View

Hahn A, Zuryn S . Mitochondrial Genome (mtDNA) Mutations that Generate Reactive Oxygen Species. Antioxidants (Basel). 2019; 8(9). PMC: 6769445. DOI: 10.3390/antiox8090392. View

Kampjut D, Sazanov L . The coupling mechanism of mammalian respiratory complex I. Science. 2020; 370(6516). DOI: 10.1126/science.abc4209. View

10.

Kluckova K, Sticha M, cerny J, Mracek T, Dong L, Drahota Z . Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation. Cell Death Dis. 2015; 6:e1749. PMC: 4669690. DOI: 10.1038/cddis.2015.110. View

11.

Vasan K, Werner M, Chandel N . Mitochondrial Metabolism as a Target for Cancer Therapy. Cell Metab. 2020; 32(3):341-352. PMC: 7483781. DOI: 10.1016/j.cmet.2020.06.019. View

12.

van Delft M, Wei A, Mason K, Vandenberg C, Chen L, Czabotar P . The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell. 2006; 10(5):389-99. PMC: 2953559. DOI: 10.1016/j.ccr.2006.08.027. View

13.

Degli Esposti M, Carelli V, Ghelli A, Ratta M, Crimi M, Sangiorgi S . Functional alterations of the mitochondrially encoded ND4 subunit associated with Leber's hereditary optic neuropathy. FEBS Lett. 1994; 352(3):375-9. DOI: 10.1016/0014-5793(94)00971-6. View

14.

Souers A, Leverson J, Boghaert E, Ackler S, Catron N, Chen J . ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013; 19(2):202-8. DOI: 10.1038/nm.3048. View

15.

Fontaine E . Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences. Front Endocrinol (Lausanne). 2019; 9:753. PMC: 6304344. DOI: 10.3389/fendo.2018.00753. View

16.

Eisner V, Picard M, Hajnoczky G . Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat Cell Biol. 2018; 20(7):755-765. PMC: 6716149. DOI: 10.1038/s41556-018-0133-0. View

17.

Bandara A, Drake J, Brown D . Complex II subunit SDHD is critical for cell growth and metabolism, which can be partially restored with a synthetic ubiquinone analog. BMC Mol Cell Biol. 2021; 22(1):35. PMC: 8196461. DOI: 10.1186/s12860-021-00370-w. View

18.

Ahn C, Lee W, Jung Y, Shin J, Hong K, Choi S . Antitumor effect of TW-37, a BH3 mimetic in human oral cancer. Lab Anim Res. 2020; 35:27. PMC: 7081630. DOI: 10.1186/s42826-019-0028-7. View

19.

Yoshino T, Shiina H, Urakami S, Kikuno N, Yoneda T, Shigeno K . Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Clin Cancer Res. 2006; 12(20 Pt 1):6116-24. DOI: 10.1158/1078-0432.CCR-06-0147. View

20.

Musiani F, Rigobello L, Iommarini L, Carelli V, Degli Esposti M, Ghelli A . New Insights on Rotenone Resistance of Complex I Induced by the m.11778G>A/ Mutation Associated with Leber's Hereditary Optic Neuropathy. Molecules. 2022; 27(4). PMC: 8876992. DOI: 10.3390/molecules27041341. View